Vitamin D levels and hormone side effects from immune cancer therapy
Part of Cancer, Hormones & metabolism clinical trials.
This study looks at whether your blood vitamin D level is linked to hormone-related side effects caused by immune checkpoint cancer drugs. It may help doctors better predict who is at risk and how to monitor patients during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (over 18) with cancer and your doctor plans immune therapy that targets PD-1 or PD-L1 as your only immunotherapy
- You are willing to take part in all study visits and complete symptom questionnaires
- You are willing to have blood drawn for the study
- Your hemoglobin level is at least 9 (your blood count is not too low)
- You are not pregnant or breastfeeding
- You are not currently taking a vitamin D supplement for vitamin D deficiency (a multivitamin is usually okay)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people’s bodies respond to cancer immunotherapy and why some people get side effects. Your information and lab results may help improve how immunotherapy is managed in the future.
This trial studies whether taking vitamin D while you are on prostate hormone therapy (ADT) affects your health outcomes. It may help by keeping vitamin D levels in a safe range during treatment.
This study looks at people with certain types of blood cancer (lymphoma or leukemia) who are getting immunotherapy drugs called checkpoint inhibitors. Researchers want to learn how these drugs affect the body's hormone system, so doctors can better manage these side effects.
This trial tests whether taking vitamin D supplements can reduce side effects from chemotherapy in people with breast cancer. It is for patients with low vitamin D levels who are about to start their first chemotherapy treatment.
This study looks at how vitamin D levels affect treatment results in women with locally advanced cervical cancer who are about to start chemoradiation (chemotherapy plus radiation). It aims to see if higher vitamin D is linked to better outcomes.
This study tracks how a type of cancer treatment called anti-PD-1 immunotherapy affects bone strength over time. Researchers want to understand whether this treatment causes bone density loss and help develop ways to protect bones during cancer care.
Hear when a new Thyroid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.